Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Breast Cancer 2022

ESMO Breast Cancer 2022: Sponsors

ESMO-Breast-Cancer-2022-1000x250

Platinum Sponsors

Daiichi Sankyo

SL-Daiichi-Sankyo-wide

With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.

Eli Lilly and Company

SL-Lilly-Oncology

For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly’s commitment to people with cancer.

Pfizer Oncology

SL-Pfizer-Oncology

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

Gold Sponsors

Astrazeneca

SL-AstraZeneca

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

Eisai Europe Ltd

SL-Eisai

At EMEA Eisai, everything we do is dedicated to giving our first thought to patients & their families through our human health care (hhc) philosophy. Our mission is clear; strive to make a significant long-lasting contribution to society in an ethical, compliant & sustainable way by embodying our hhc philosophy in everything we do.

Gilead

SL-Gilead-Oncology

At Gilead and Kite, we focus on delivering therapies for patients with some of the most difficult-to-treat cancers. The medicines in our pipeline are being developed to treat cancer by harnessing the power of cell therapy, targeting immune evasion pathways and leveraging first-in-class antibody drug conjugate technology.

MSD

SL-MSD

For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.

Novartis

SL-Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development.

Pierre Fabre

SL-Pierre-Fabre

Pierre Fabre is a French health and beauty care company. Oncology is one of its top priorities with a focus on targeted therapies, biotherapies and immuno-oncology, in therapeutic areas such as colorectal, breast as well as lung cancers and melanoma. In 2020, Pierre Fabre generated EUR 2.3 billion in revenues.

Roche

SL-Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives and personalised healthcare. Its headquarters are in Basel, Switzerland.

Sanofi

SL-Sanofi

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Seagen

SL-Seagen

Seagen is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development.

Silver Sponsors

Exact Sciences

SL-ExactSciences

Exact Sciences is a leading, global cancer diagnostics company. From early detection to diagnosis and treatment guidance, the company is offering and further developing a suite of tests to enable personalised care at all stages of the disease. In   early breast cancer, the Oncotype DX test is the only test validated to identify patients likely to benefit from chemotherapy.

Myriad Genetics

SL-Myriad

Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health for all, empowering individuals with vital genetic insights and enabling physicians to better detect, treat and prevent disease. Myriad provides tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions to significantly improve patient care.

Bronze Sponsor

Agendia

SL-Agendia-mp-bp

Agendia is a molecular diagnostics company committed to improving clinical outcomes and informing the journey for early-stage breast cancer patients. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre-and post-operative settings. By developing evidence-based, novel genomic tests, Agendia aims to support the evolving clinical needs of patients and their physicians.

Supporters

Cerca Biotech GmbH

SL-Cerca-Biotech

Cerca Biotech is a German based company specialising in Women’s Health and Oncology, we have recently acquired the MammaTyper® assay for breast cancer diagnosis, the first to market of a range of molecular oncology diagnostic assays. Also we will shortly launch our new CercaTest™ Pre-eclampsia Vue™ assay.

Reveal Genomics 

SL-Reveal-Genomics

Reveal Genomics, S.L. is a biotechnology start-up seeking to change the way biomarkers are used in oncology. It is focused on developing innovative diagnostic tools to define the best therapeutic options for patients with cancer. The company uses pioneering techniques, sophisticated computer applications, and machine learning to reveal new cancer research data. 

Sysmex Europe GmbH

SL-Sysmex

Sysmex Europe GmbH is a subsidiary of the Sysmex Corporation. For over 50 years, we have actively set new standards and driven innovation in haematology and our other areas of expertise. We’re now among Europe’s top laboratory diagnostics and healthcare companies, and the global leader for haematology diagnostics and service.

Veracyte, Inc.

SL-Veracyte

Veracyte is a global diagnostics company that improves care throughout the patient journey. Our advanced diagnostic tests answer important clinical questions in eight of ten most prevalent cancers by incidence in the United States. Our solutions help patients avoid risky, costly procedures and interventions, and reduce time to appropriate treatment.

Societies

ABC Global Alliance

SL-ABC-Global-Alliance

The ABC Global Alliance is a is a multi-stakeholder platform for all those interested in collaborating on common projects relating to advanced breast cancer (ABC) around the world. We are made up of people and organisations who are committed to develop, promote and support tangible improvements that will ultimately create awareness and actions to improve and extend the lives of patients living with ABC worldwide.

ESMO

With more than 25,000 members representing professionals from 160+ countries, ESMO is the leading professional organisation for medical oncology and the society of reference for oncology education and information. Driven by the determination to secure the best possible outcomes for patients, ESMO stands by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE.

  • Booth number: 15
  • Virtual Booth

ESO

ESO logo 40 years

The European School of Oncology (ESO) is an independently funded non-profit organisation dedicated to quality education and training, because we believe all patients deserve equal access to competent cancer care. Our Vision: “To ensure that all cancer patients have access to unbiased and evidence-based competent care from adequately trained health professionals”.

GBG Forschungs GmbH – German Breast Group

GBG-Logo

GBG Forschungs GmbH is a professional institute dedicated to breast cancer research led by Prof. Dr. med. Sibylle Loibl (CEO). The institute serves Germany's largest breast cancer Study group, the German Breast Group, as a platform for implementing academically orientated clinical trials

Breastanbul

Breastanbul

Breastanbul was launched in 2014 as the brand of scientific convention exclusively focusing on breast cancer. It aims to bring all related disciplines (Medical Oncology, Breast Surgery, Radiology, Radiation Oncology, Reconstructive and Aesthetic Surgery, Nursing)  together to promote and discuss the cutting-edge research with the goal of strengthening collaborative management of the disease and enhancing holistic patient care. 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.